Variety and irreversibility in scientific and technological systems: The evolution of an industry network

The Evolution of Economic Diversity

Volumn , Issue , 2013, Pages 216-239

  Pammolli, Fabio ^a   Orsenigo, Luigi ^b   Riccaboni, Massimo ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b BOCCONI UNIVERSITY   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85071777437     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (37)

1. Agresti, F. (1990) Categorical Data AnalYsis. New York: John Wiley
2. Arora, A. and A. Gambardella (1994) Evaluating technological information and utilizing it: scientific knowledge, technological capability and external linkages in biotechnology. Journal of Economic Behavior and Organization 24: 91-114
3. Barley, S.R., D. Freeman and R. C. Hybels (1992) Strategic alliances in commercial biotechnology. In N. Nohria and R.G. Eccles (eds) Networks and Organizations. Cambridge MA: Harvard Business School Press
4. Bioscan (1988-1993) The biotechnology corporate directory service, Phoenix, AR
5. Bonaccorsi, A. and F. Pammolli (1997) Technical development, design, and the division of innovative labour. InternationalJournal ofTechnology Management. Special issue on 'Structural change, institutional change and models of capitalism'. Forthcoming
6. David, P.A., D. Mowery and w.E. Steinmuller (1992) Analysing the economic payoffs from basic research. Economics of Innovation and New Technology 2: 73-90
7. Dosi, G. (1988) Sources, procedures and microeconomic effects of innovation. Journal of Economic Literature 26: 112D-1171
8. Dosi, G. and M. Egidi (1991) Substantive and procedural uncertainty. Journal ofEvolutionary Economics I: 145-168
9. Dosi, G., L. Marengo and G. Fagiolo (1996) uarning in Evolutionary Environments. WP 96-124. Laxenburg: IIASA
10. Galambos, L. and]. Sturchio (1996) The pharmaceutical industry in the twentieth century: a reappraisal of the sources of innovation. History and Technology 13(2): 83-100
11. Gambardella, A. (1995) Science and Innovation: The US Pharmaceutical Industry During the 1980s. Cambridge: Cambridge University Press
12. Granstrand, 0., P. Patel and K. Pavitt (1997) Why they have 'distributed' rather than 'distinctive core' competencies. California Management Review 39(4): 8-25
13. Henderson, R., L. Orsenigo and G. Pisano (1997) The Pharmaceutical Industry and the Revolution in Molecular Biology: Exploring the Interactions Between Scientific, Institutional and Organizational Change. Mimeo. CCC Matrix
14. Kogut, B., W. Shan and G. Walker (1992) The make-or-cooperate decision in the context of an industry network. In N. Nohria and R.G. Eccles (eds) Networks and Organizations. Cambridge, MA: Harvard Business School Press
15. Levinthal, D. (1996) Organizations and Capabilities: The Role ofDecompositions and Units of Selection. Mimeo. Wharton School, University of Pennsylvania
16. Malerba, F. and L. Orsenigo (1996) The dynamics and evolution of industries. Industrial and Corporate Change 5(1): 51-88
17. March, ]. G. (1991) Exploration and exploitation in organizational learning. Organization Science 2(1): 71-87
18. Nelson, R.R. (1961) Uncertainty, learning and economics of parallel research and development efforts. Review ofEconomics and Statistics. 43: 351-364
19. Nelson, R.R. and S.G. Winter (1982) An Evolutionary Theory of Economic Change. Cambridge, MA: Harvard University Press
20. Orsenigo, L. (1989) The Emergence of Biotechnology. New York: St. Martins Press
21. Orsenigo, L., F. Pammolli and M. Riccaboni (1996) A Model ofNetwork Evolution in Biotechnology. Mimeo
22. Pammolli, F. (1996) Innovazione, concorrenza e strategie di sviluppo nell'industriafarmaceutica. Milan: Guerini
23. Pattison, P. (1993) Algebraic Modelsfor Social Networks. Cambridge: Cambridge University Press
24. Pisano, G.P. (1991) The governance of innovation: vertical integration and collaborative arrangements in the biotechnology industry. Research Poliq 20: 237-249
25. Powell, w.w. (1996) Interorganizational collaboration in the biotechnology industry, Journal of Institutional and Theoretical Economics 152(1): 197-215
26. Powell, w.w., K.w. Doput and L. Smith-Doerr (1996) Interorganizational collaboration and the locus of innovation: networks oflearning in biotechnology. Administrative Science Qyarterry 41: 116-145
27. Schaffner, K.F. (1986) Exemplar reasoning about biological models and diseases: a relation between the philosophy of medicine and philosophy of science. The Journal of Medicine and Philosophy 11: 63-80
28. Schwartzman, D. (1976) Innovation in the Pharmaceutical Industry. Baltimore: Johns Hopkins University Press
29. Scott, ]. (1991) Social Network Anarysis: A Handbook. London: Sage
30. Simon, H.A. (1969) The architecture of complexity. In The Sciences oftheArtijicial. Cambridge, MA: MIT Press
31. Suitor, JJ., B. Wellman and D. L. Morgan (1997) It's about time: how, why, and when networks change. Social Networks 19: 1-7
32. Testa, B. and u.A. Meyer (1995) Advances in Drug Research. New York: Academic Press
33. Vos, R. (1991) Drugs Lookingfor Diseases. Dordrecht: Kluwer Academic Publishers
34. Walker, G., B. Kogut and W. Shan (1997) Social capital, structural holes and the formation of an industry network. Organization Science 8(2): 109-125
35. Wasserman, S. and K. Faust (1994) Social Network Anarysis: Methods and Applications. Cambridge: Cambridge University Press
36. Winter, S.G. (1984). Schumpeterian competition in alternative technological regimes. Journal of Economic Behavior and Organization 287-320
37. Zucker, L.G. and M.R. Darby (1995) Present at the revolution: transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough. NEER. WP 5243, August. Cambridge, MA